Literature DB >> 10051496

Viral load and clinicopathological features of chronic hepatitis C (1b) in a homogeneous patient population.

L Fanning1, E Kenny, M Sheehan, B Cannon, M Whelton, J O'Connell, J K Collins, F Shanahan.   

Abstract

Monitoring the progression of hepatitis C virus (HCV) includes clinical, biochemical, and histological parameters. Quantitation of viral load by reverse-transcription polymerase chain reaction (RT-PCR) may offer a more reliable marker of disease status. Conflicting reports on viral titers may reflect heterogeneity of patient population, mode of infection, and viral type/subtype. The aim of this study was to correlate quantitative serum viral load with alanine transaminase (ALT) and histological status in a homogenous population. The study population consisted of 77 Rhesus-negative women with chronic hepatitis C type 1b. Homogenous features of this study population included: same defined source of infection (contaminated anti-D immunoglobulin); same duration of disease (17 years at the time of study); same viral type/subtype; same ethnic origin; all healthy child-bearing females at the time of infection; and an absence of competing risk factors for infectious and other liver diseases. None of the patients had received antiviral treatment at the time of study. Liver biopsy was performed on all patients. All biopsies were scored by a single histopathologist who was blinded to the clinical and viral status of each patient. A weak, but statistically significant, correlation (rs =.26; P <.05) between serum viral load and the degree of inflammation (mean value: 3.87 +/- 2.17 [SD]) was found. There was no significant correlation between serum viral load and the degree of fibrosis (mean value: 0.84 +/- 0.8 [SD]; P =.06). There was no significant correlation between serum viral load and ALT, although there was a correlation between ALT and the degree of inflammation (rs =.241; P =.035).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051496     DOI: 10.1002/hep.510290310

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  25 in total

Review 1.  Quantitative molecular analysis of virus expression and replication.

Authors:  M Clementi
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Reciprocal interaction of human immunodeficiency virus and hepatitis C virus infections.

Authors:  K E Nelson; D L Thomas
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

3.  Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time.

Authors:  L Martin Lagging; Clementina E Garcia; Johan Westin; Rune Wejstål; Gunnar Norkrans; Amar P Dhillon; Magnus Lindh
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver.

Authors:  B Cabot; M Martell; J I Esteban; S Sauleda; T Otero; R Esteban; J Guàrdia; J Gómez
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Differences in the factors associated with serum viral load between genotypes 1 and 2 in patients with chronic hepatitis C.

Authors:  Shunsuke Sato; Takuya Genda; Katsuharu Hirano; Hironori Tsuzura; Yoshio Kanemitsu; Yutaka Narita; Tetsu Kikuchi; Katsuyori Ijima; Takafumi Ichida
Journal:  Hepatol Int       Date:  2011-04-02       Impact factor: 6.047

6.  Hepatitis C in Laos: A 7-Year Retrospective Study on 1765 Patients.

Authors:  Phimpha Paboriboune; Thomas Vial; Philavanh Sitbounlang; Stéphane Bertani; Christian Trépo; Paul Dény; Francois-Xavier Babin; Nicolas Steenkeste; Pascal Pineau; Eric Deharo
Journal:  Virol Sin       Date:  2018-06-13       Impact factor: 4.327

Review 7.  Hepatitis C virus infection in HIV-infected patients.

Authors:  Mark S Sulkowski
Journal:  Curr HIV/AIDS Rep       Date:  2004-09       Impact factor: 5.071

8.  Vitamin B12 and hepatitis C: molecular biology and human pathology.

Authors:  W B Lott; S S Takyar; J Tuppen; D H Crawford; M Harrison; T P Sloots; E J Gowans
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

9.  Feasibility of histological grading and staging of chronic viral hepatitis using specimens obtained by thin-needle biopsy.

Authors:  Daniela Petz; Sabine Klauck; Friedrich-Wilhelm Röhl; Peter Malfertheiner; Albert Roessner; Christoph Röcken
Journal:  Virchows Arch       Date:  2003-01-28       Impact factor: 4.064

Review 10.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.